Should PD-L1 be Used as a Biomarker for Immunotherapy in Lung Cancer_ [360p]

Should PD-L1 be Used as a Biomarker for Immunotherapy in Lung Cancer_ [360p]

User Photo
cancergrace

1 year
144 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Dr. Eddie Garon, UCLA, reviews the controversial question of whether PD-L1 expression is a reliable enough biomarker to be used to select patients to receive or not receive immune checkpoint inhibitor therapy in lung cancer.
Up Next Autoplay